Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Clinical trial NCT04166565 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04166565
- Sponsor
- Stichting European Myeloma Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2027-03-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.